Zusammenfassung
Herzversagen ist bei Patienten über 65 Jahren häufig die Indikation für eine Krankenhausaufnahme. Die Herzinsuffizienz ist neben der hochgradigen Aortenstenose und deutlich vor der KHK der wichtigste Risikofaktor für die Morbidität und Letalität bei nichtkardiochirurgischen Operationen und die perioperative 30-Tages-Letalität von Patienten mit Herzinsuffizienz nach großen, nichtkardiochirurgischen Eingriffen ist etwa doppelt so hoch wie bei Patienten ohne Herzinsuffizienz. Das anästhesiologische Management orientiert sich am Schweregrad und Pathomechanismus der Herzinsuffizienz und wird in diesem Kapitel vorgestellt.
This is a preview of subscription content, log in via an institution.
Literatur
Antonini M, Stazi GV, Cirasa MT, Garotto G, Frustaci A (2010) Efficacy of levosimendan in Takotsubo-related cardiogenic shock. Acta Anaesthesiol Scand 54(1):119–120
Carl M, Alms A, Braun J, Dongas A, Erb J, Goetz A, Goepfert M, Gogarten W, Grosse J, Heller AR, Heringlake M, Kastrup M, Kroener A, Loer SA, Marggraf G, Markewitz A, Reuter D, Schmitt DV, Schirmer U, Wiesenack C, Zwissler B, Spies C (2010) S3 guidelines for intensive care in cardiac surgery patients: hemodynamic monitoring and cardiocirculary system. Ger Med Sci 15:8
De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ (2007) The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 104:766–773
DGAI, DGC, DGIM (2017) Preoperative evaluation of adult patients prior to elective, non-cardiac surgery: joint recommendations of German Society of Anesthesiology and Intensive Care Medicine, German Society of Surgery and German Society of Internal Medicine. Anaesthesist 66:442–458
Fazio G, Pizzuto C, Barbaro G, Sutera L, Incalcaterra E, Evola G, Azzarelli S, Palecek T, Di Gesaro G, Cascio C, Novo G, Akashi YJ, Novo S (2008) Chronic pharmacological treatment in takotsubo cardiomyopathy. Int J Cardiol 127(1):121–123
Fuhrmann JT, Schmeisser A, Schulze MR et al (2008) Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Crit Care Med 36:2257–2266
Groban L, Butterworth J (2006) Perioperative management of chronic heart failure. Anesth Analg 103:557–575
Hensley N, Dietrich J, Nyhan D, Mitter N, Yee MS, Brady M (2015) Hypertrophic cardiomyopathy: a review. Anesth Analg 120(3):554–569
Hernandez AF, Whellan DJ, Stroud S et al (2004) Outcomes in heart failure patients after major noncardiac surgery. J Am Coll Cardiol 44:1446–1453
Jabaudon M, Bonnin M, Bolandard F, Chanseaume S, Dauphin C, Bazin JE (2007) Takotsubo syndrome during induction of general anaesthesia. Anaesthesia 62(5):519–523
Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007–2018
Jung J, Schreiber JU (2003) Current treatment of chronic heart failure. Anaesthesist 52:612–618
Kerbaul F, Rondelet B, Demester JP et al (2006) Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med 34:2814–2819
Liu S, Bravo-Fernandez C, Riedl C, Antapli M, Dhamee MS (2008) Anesthetic management of Takotsubo cardiomyopathy: general versus regional anesthesia. J Cardiothorac Vasc Anesth 22(3):438–441
Maisel AS, Krishnaswamy P, Nowak RM et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167
Mebazaa A, Karpati P, Renaud E, Algotsson L (2004) Acute right ventricular failure – from pathophysiology to new treatments. Intensive Care Med 30:185–196
Mets B (2015) To stop or not? Anesth Analg 120(6):1413–1419
Missant C, Rex S, Segers P, Wouters PF (2007) Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction. Crit Care Med 35:707–715
Nef HM, Möllmann H, Hilpert P, Masseli F, Kostin S, Troidl C, Rolf A, Dill T, Weber M, Hamm C, Elsässer A (2008) Sympathoadrenergic overstimulation in Tako-Tsubo cardiomyopathy triggered by physical and emotional stress. Int J Cardiol 130(2):266–268
Nef HM, Möllmann H, Akashi YJ, Hamm CW (2010) Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol 7(4):187–193
Pilgrim TM, Wyss TR (2008) Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome: a systematic review. Int J Cardiol 124(3):283–292
Poelzl G, Zwick RH, Grander W et al (2008) Safety and effectiveness of levosimendan in patients with predominant right heart failure. Herz 33:368–373
Quintin L, Bouilloc X, Butin E et al (1996) Clonidine for major vascular surgery in hypertensive patients: a double-blind, controlled, randomized study. Anesth Analg 83:687–695
Roggenbach J, Roggenbach R, Ehlermann P (2010) Tako-Tsubo cardiomyopathy]. Anaesthesist 59:636–642
Ryding AD, Kumar S, Worthington AM, Burgess D (2009) Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis. Anesthesiology 111:311–319
Takizawa M, Kobayakawa N, Uozumi H, Yonemura S, Kodama T, Fukusima K, Takeuchi H, Kaneko Y, Kaneko T, Fujita K, Honma Y, Aoyagi T (2007) A case of transient left ventricular ballooning with pheochromocytoma, supporting pathogenetic role of catecholamines in stress-induced cardiomyopathy or takotsubo cardiomyopathy. Int J Cardiol 114(1):e15–e17
Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Böhm M, Ebelt H, Schneider S, Schuler G, Werdan K (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287–1296
Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352(6):539–548
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128(16):1810–1852
Zwissler B (2002) Inhalierte Vasodilatatoren. Anaesthesist 51:603–622
Deutsche Gesellschaft für Kardiologie-Herz- und Kreislaufforschung (2017). Infarkt-bedingter kardiogener Schock - Diagnose, Monitoring und Therapie. AWMF-Leitlinien-Register Nr. 019/013
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 © Springer-Verlag GmbH Deutschland
About this entry
Cite this entry
Zwißler, B., Boost, K.A. (2018). Anästhesie bei Patienten mit Herzinsuffizienz. In: Rossaint, R., Werner, C., Zwißler, B. (eds) Die Anästhesiologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45539-5_90-2
Download citation
DOI: https://doi.org/10.1007/978-3-662-45539-5_90-2
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45539-5
Online ISBN: 978-3-662-45539-5
eBook Packages: Springer Referenz Medizin
Publish with us
Chapter history
-
Latest
Anästhesie bei Patienten mit Herzinsuffizienz- Published:
- 15 March 2018
DOI: https://doi.org/10.1007/978-3-662-45539-5_90-2
-
Original
Anästhesie bei Patienten mit Herzinsuffizienz- Published:
- 12 August 2017
DOI: https://doi.org/10.1007/978-3-662-45539-5_90-1